Syndax Pharmaceuticals (SNDX) PT Lowered to $33 at JPMorgan
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $19.08 -3.64%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $33.00 (from $40.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
- Hon Hai Precision Industry Co Ltd. (2317:TT) (HNHPD) PT Raised to NT$435 at Macquarie
- Cellebrite (CLBT) PT Lowered to $15 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
